share_log

HC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $105 Price Target

Benzinga ·  Apr 26 07:06

HC Wainwright & Co. analyst Douglas Tsao reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $105 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment